|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,797.00 GBX | +2.39% |
|
-0.66% | -34.29% |
| 03:47am | Bellway sticks with annual outlook but demand cools in April and May | AN |
| 02:59am | GSK agrees to buy US cancer drug maker Nuvalent | AN |
Company Valuation: Bellway p.l.c.
Data adjusted to current consolidation scope
| Fiscal Period: July | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,049 | 3,012 | 2,664 | 3,401 | 2,963 | 2,015 | - | - |
| Change | - | -25.6% | -11.55% | 27.64% | -12.87% | -32% | - | - |
| Enterprise Value (EV) 1 | 3,719 | 2,767 | 2,432 | 3,411 | 2,921 | 2,066 | 1,990 | 1,922 |
| Change | - | -25.59% | -12.1% | 40.24% | -14.37% | -29.29% | -3.65% | -3.4% |
| P/E ratio | 10.4x | 12.5x | 7.48x | 26.3x | 18.9x | 9.7x | 9.47x | 7.88x |
| PBR | 1.23x | 0.9x | 0.77x | 0.98x | 0.83x | 0.57x | 0.54x | 0.52x |
| PEG | - | -0.3x | 0.1x | -0.4x | 0.9x | 0.3x | 3.9x | 0.4x |
| Capitalization / Revenue | 1.3x | 0.85x | 0.78x | 1.43x | 1.06x | 0.66x | 0.64x | 0.61x |
| EV / Revenue | 1.19x | 0.78x | 0.71x | 1.43x | 1.05x | 0.67x | 0.63x | 0.58x |
| EV / EBITDA | 6.91x | 4.2x | 4.42x | 14x | 9.45x | 6.33x | 5.97x | 4.84x |
| EV / EBIT | 7x | 4.24x | 4.47x | 14.3x | 9.62x | 6.47x | 6.12x | 5.03x |
| EV / FCF | 8.66x | 24.3x | 10.4x | -51x | 13.9x | 20.8x | 9.02x | 8.13x |
| FCF Yield | 11.5% | 4.12% | 9.6% | -1.96% | 7.19% | 4.8% | 11.1% | 12.3% |
| Dividend per Share 2 | 1.175 | 1.4 | 1.4 | 0.54 | 0.7 | 0.7518 | 0.7882 | 0.9359 |
| Rate of return | 3.58% | 5.72% | 6.32% | 1.88% | 2.81% | 4.28% | 4.49% | 5.33% |
| EPS 2 | 3.158 | 1.962 | 2.963 | 1.09 | 1.318 | 1.81 | 1.854 | 2.228 |
| Distribution rate | 37.2% | 71.4% | 47.2% | 49.5% | 53.1% | 41.5% | 42.5% | 42% |
| Net sales 1 | 3,122 | 3,537 | 3,407 | 2,380 | 2,783 | 3,062 | 3,154 | 3,315 |
| EBITDA 1 | 538 | 659.3 | 549.9 | 243.2 | 309 | 326.4 | 333.5 | 396.9 |
| EBIT 1 | 531.5 | 653.2 | 543.9 | 238.1 | 303.5 | 319.1 | 325.1 | 381.9 |
| Net income 1 | 390.7 | 242.6 | 365 | 130.5 | 157.5 | 201.6 | 202.3 | 235.6 |
| Net Debt 1 | -330.3 | -245.3 | -232 | 10.5 | -41.8 | 50.74 | -24.72 | -92.37 |
| Reference price 2 | 32.82 | 24.46 | 22.16 | 28.66 | 24.90 | 17.55 | 17.55 | 17.55 |
| Nbr of stocks (in thousands) | 123,366 | 123,152 | 120,231 | 118,654 | 118,989 | 114,804 | - | - |
| Announcement Date | 10/19/21 | 10/18/22 | 10/17/23 | 10/15/24 | 10/14/25 | - | - | - |
1GBP in Million2GBP
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 9.74x | 0.67x | 6.32x | 4.28% | 2.7B | ||
| 13.64x | 1.29x | 9.93x | 1.24% | 40.91B | ||
| 11.74x | 1.35x | 8.1x | 0.86% | 22.42B | ||
| 8.79x | 0.86x | 7.23x | 4.12% | 16.42B | ||
| 9.44x | 0.78x | 8.33x | 4.46% | 13.16B | ||
| 10.76x | 1.3x | 7.72x | 0.75% | 12.82B | ||
| 13.56x | 1.14x | 9.92x | -.--% | 6.67B | ||
| 13.2x | 0.71x | 5.59x | 3.45% | 5.84B | ||
| 8.68x | 0.77x | 10.01x | 3.86% | 4.96B | ||
| 10.21x | 0.51x | 5.03x | 5.66% | 4.75B | ||
| Average | 10.98x | 0.94x | 7.82x | 2.87% | 13.07B | |
| Weighted average by Cap. | 11.58x | 1.10x | 8.46x | 2.17% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BWY Stock
- Valuation Bellway p.l.c.
Select your edition
All financial news and data tailored to specific country editions
















